You are reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks
Wall Street has surprised with rallies despite rising Delta variant cases. However, investors are on the edge considering certain factors that may affect the current investment environment. Factors such as rising Delta variant cases and the Federal Reserve meeting announcing plans to buy bond purchases are also raising concerns. U.S. consumers also appear to be concerned about the sustainability of the economic recovery following the pandemic-led downturn, rising Delta variant threat and rising inflation levels.
To further reinforce investor concerns, September is historically considered the worst-performing month for Wall Street. Analysts expect a market correction in September. According to LPL Financial data published in a Yahoo Finance article, the S&P 500 has fallen by an average of 1% in September since 1950. Some recent financial data releases also proved to be very disappointing. The U.S. economy added only 235,000 jobs in August 2021 (the lowest in seven months).
Meanwhile, the FDA, which has given the first full US approval to Pfizer (PFE) / BioNTechs (BNTX) coronavirus vaccine, Comirnaty (BNT162b), has also boosted investor confidence. Full FDA approval is expected to increase confidence in imposing vaccine mandates. Also, the unvaccinated population is now more likely to opt for vaccinations.
Given the mixed sentiments, mid-cap funds are gaining increased attention as they provide both growth and stability relative to small-cap and large-cap counterparties. As such, investors looking to capitalize on the strong fundamentals but concerned about uncertainty should consider mid-cap ETFs. Here we have presented five popular mid-cap ETFs as Vanguard Mid-Cap ETF VO, SPDR S&P MIDCAP 400 ETF Trust MDY, iShares Russell Mid-Cap Value ETF IWS, Vanguard Mid-Cap Growth ETF VOTE and Schwab US Mid-Cap ETF SCHM.
Time to invest in legal marijuana
If you’re looking for big gains, there could not be a better time to enter a young industry that was ready to skyrocket from $ 17.7 billion back in 2019 to an expected $ 73.6 billion in 2027.
After a clean sweep of 6 polls in 5 states, pot is now legal in 36 states plus DC Federal legalization is expected soon and it could be an even bigger bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot holdings that have shot up to + 285.9%.
You are invited to check out Zacks’ Marijuana Money Developers: An investor guide. It contains a timely watch list of pot stocks and ETFs with exceptional growth potential.
Download today FREE marijuana money developers >>
Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks in the next 30 days. Click to get this free report
SPDR S&P MidCap 400 ETF (MDY): ETF Research Reports
Schwab US MidCap ETF (SCHM): ETF Research Reports
iShares Russell MidCap Value ETF (IWS): ETF Research Reports
Vanguard MidCap Growth ETF (VOT): ETF research reports
Vanguard MidCap ETF (VO): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research